State of Suspension and Debarment
Client Alert | less than 1 min read | 08.10.18
The Interagency Suspension and Debarment Committee recently issued its report on FY2017 exclusion statistics. The report highlighted a substantial decline in numbers of exclusions (approximately 14 percent) and an increase in numbers of proactive contractor outreach efforts to SDOs. While the decline in overall governmentwide exclusion activity does not directly correlate with increased proactive contractor engagement, the overarching message from this report is the value of contractor outreach to suspending and debarring officials to avoid being excluded from government contracting and federal assistance programs.
Contacts
Insights
Client Alert | 4 min read | 04.18.24
Following federal lawmakers’ initiative to lower prescription drug prices under the Inflation Reduction Act of 2022, several states have taken similar steps to limit certain drugs’ prices. Drug affordability for consumers is a top priority for federal and state lawmakers and regulators because it is a bipartisan issue that directly impacts consumers’ wallets. With negotiations between the federal government and drug manufacturers over 10 drugs’ prices for Medicare beneficiaries well underway under the Inflation Reduction Act, 11 states, including Maryland and Colorado, have created drug affordability review boards to more directly tackle rising prices for both brand and generic drugs.[1] And another 12 states have pending legislation to create these boards.[2]
Client Alert | 6 min read | 04.16.24
Navigating the AI Intellectual Property Maze - Key Points From Congressional Hearing
Client Alert | 5 min read | 04.15.24
Making the EU Courts More Efficient for Trade-Related Decisions
Client Alert | 1 min read | 04.15.24
New FAR Part 40 to Address Supply Chain and Information Security Requirements
